is a global generic pharmaceutical company with focus on the US, Europe, Russia and India. Finished dosage and API account for a bulk of the revenues, with up to 60% of sales deriv ed from overseas operations. With a strong research pipeline, it s R&D; is focused in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infections. Dr. Reddy's offers a portfolio of products and servic es including APIs, custom pharmaceutical services, generic s, biosimilars, differentiated formulations and NCEs. It has one of the largest ANDA & patent challenge pipelines has strengthened presence through the launch of several...